Intervet/Schering-Plough Animal Health has released diagnostic data which the company says indicates that calf scour problems caused by cryptosporidia are on the increase.

A summary of 2010 results from the company's ScourCheck scheme, which identifies infectious scour pathogens in calf faeces, show the protozoan parasite Cryptosporidium parvum being present in 37% of samples.

Intervet/Schering-Plough ruminant veterinary adviser Drew McGurren said: "Ever since we started testing calf faecal samples in the 1990s, rotavirus and cryptosporidia have always been identified as the two main pathogens implicated in infectious scour problems. But the latest data - and feedback from vets in practice - suggest cryptosporidia incidence is on an upward trend.

"Ten years ago our top line reporting used to refer to rotavirus being implicated in around a third of all infectious calf scour problems and cryptosporidia in roughly a quarter. But in 2009, we detected cryptosporidia in 30% of samples. And this year - from the 250 plus faecal samples we have looked at so far - the incidence seems to be even higher."

Drew stressed that scours caused by cryptosporidia are not always confined to housed calves: "Suckler calves between one and two weeks of age can be very susceptible to infection at grass, particularly if conditions underfoot are muddy around ring feeders. Early May has seen quite a lot of rain, and the parasite thrives in damp conditions."

The major source of cryptosporidia is thought to be either adult cows (which act as carriers without showing signs of disease) or infected scouring calves passing the parasite in their faeces. Drew said: "The infectious dose of the organism is very low and if ring feeders are not moved regularly the disease threat that builds up can be very similar to the housed situation. Faecal contamination of feed and water troughs can also be reduced by raising and covering them.

"Cryptosporidiosis in calves is often seen in combination with other diseases, particularly rotavirus. So vaccinating cows against rotavirus with Rotavec-Corona one to three months pre-calving - as well as a sound colostrum feeding regime and maintaining high hygiene standards - can often tip the balance in your favour."

Intervet Schering-Plough says that if cryptosporidia is diagnosed as the problem, parasite replication and excretion can be reduced with Halocur. This is the only product licensed to treat and prevent cryptosporidiosis. Administered orally to calves after feeding (daily for seven days), it can reduce the severity of diarrhoea and prevent the infection spreading to other calves. Treated calves have also been shown to require fewer antibiotic and anti-inflammatory treatments, as well as less rehydration therapy.

RCVS Day - the Royal College of Veterinary Surgeons Annual General Meeting and Presentation of Awards - will be held on Friday 1 July 2011 at One Great George Street, London.

All members and listed/registered veterinary nurses are invited to attend the day, which will start at 10am with AGM business, followed by the celebration of veterinary and veterinary nursing achievements. Professor Soraya Shirazi-Beechey will be receiving her Honorary Associateship and Dr James Kirkwood and Des Thompson will be accepting their Honorary Fellowships.

A new award to mark the 50^th anniversary of veterinary nursing will also be presented, as well as a Lifetime Contribution Award from the RCVS Charitable Trust.

In his last official engagement as President, Peter Jinman will give a review of his year before formally welcoming new Council and VN Council Members, and Dr Jerry Davies to the role of President for 2011-2012.

To celebrate Vet2011, the RCVS is honoured to announce that there will be two guest speakers this year - Dr Christophe Buhot DVM and Professor Gary England FRCVS, who will deliver a talk about the history and future direction of veterinary education.

For tickets, which are free and allocated on a first-come, first-served basis, please contact Fiona Harcourt at the RCVS on f.harcourt@rcvs.org.uk or 020 7202 0773.

Elanco is to hold a seminar on piglet gut health, to help support the transition away from medicinal zinc usage to control post-weaning diarrhoea (PWD), at the Jury’s Inn hotel, near Hinckley, Leicestershire, on 21st September from 11am – 1pm.

Leading industry experts including Faye Murch from Kingsgate Nutrition, Eric Nadeau, Elanco Global Pig Vaccine Advisor, veterinary consultant Daniel Parker and Francesc Molist from Schothorst Feed Research will share their learnings on alternative approaches to managing PWD, including vaccination.

Jack Fellows from Elanco Animal Health says that with 90% of producers using their vet as their first port of call when it comes to PWD¹, it is vital they start to encourage producers to consider an alternative prescription to zinc.

He said: “Producers must start to prepare now to avoid being forced to turn to antibiotics when zinc is no longer an option.

"Vaccination will become an increasingly important component of PWD prevention. Amongst other topics on mastering piglet gut health, the seminar aims to support knowledge on the application of in-water vaccines to ensure appropriate and effective use.”

Jack says that while vaccination may appear costly in comparison to zinc oxide, it offers a good return on investment: "Piglets can be vaccinated from 18 days of life, so they are protected from the pathogen at weaning, and we are seeing a growing number of UK herds using vaccines as part of their PWD prevention strategy.

"Farms using the Coliprotec vaccine are no longer using in-water medication to control scours. They’re also noticing that piglets are eating more, and that they’re achieving an extra 2kg of slaughter weight² while reaching market weights seven days sooner³.”

To register for the event, visit: https://www.myelanco.co.uk/pub/swine-seminar-registration 

References

1. Elanco Market Research Farmers Weekly Post Weaning Diarrhoea Research 2020 (v1.0)
2. Purina Mills Purina Mills EACH PRODUCTION PHASE IMPACTS THE NEXT 2015 (v1.0)
3. Vangroenweghe F et al 10th European Symposium of Porcine Health Management 2018 254 (v1.0)

Dechra Veterinary Products is encouraging veterinary practitioners to find the cat that has been treated with Felimazole^® for the longest period of time, for the chance to win a luxury chocolate hamper.

The company wants to gather profiles of hyperthyroid cats undergoing treatment, including their age and length of treatment, so that it can further inform the veterinary profession about feline hyperthyroidism, the most at-risk cats and how to successfully treat the condition with the leading product Felimazole.

Practitioners simply need to provide details of their patient's age, when the cat was diagnosed with hyperthyroidism and how long it has been treated with Felimazole. Submissions will be entered into a prize draw with the first placed practice and cat's owner each winning a luxury chocolate hamper, while second and third places will receive luxury chocolate boxes.

Carol Morgan, Felimazole product manager at Dechra Veterinary Products says: "The majority of cats suffering with hyperthyroidism are over seven years of age, so we are interested in finding the longest-treated and the current ages of cats on Felimazole. The information we receive from practitioners is invaluable, so we will collate and report our findings to the veterinary profession to ensure it has the most up-to-date information about the disease."

For details of how to enter the competition, contact your local Dechra territory manager, call Dechra on 01743 441632 or email marketing@dechra.com.

Vetoquinol has released the second set of results from a survey of over 1000 dog owners which the company says has revealed some surprising findings on owner attitudes to pain and pain relieving medications.¹

In particular, Vetoquinol says it thinks veterinary surgeons will be surprised by the depth of feeling expressed by pet owners about the issue, and that there are areas where there is potential for the profession to relate to the concerns of clients and adapt communication accordingly.

The key findings highlight that dog owners are likely to be shocked by a diagnosis of long term painful illness in their pet and are very likely to search for further information on the Internet about the pet's condition. Most dog owners think that NSAIDs are likely to cause side effects, with the perceived risk being much greater than the actual level of risk. The results also indicate that even low levels of risk of side effects may be unacceptable to dog owners.

• In common with many other surveys, most dog owners (68%) felt their dog was a member of the family and another 22% said their dog was their best friend.
• 73% of people selected the word 'devastated' to most accurately describe their feelings if their dog was diagnosed with a potentially painful long-term illness.

Mark Leddy, Marketing Manager at Vétoquinol said that the strength of the bond between pet and owner should always be front of mind: "A diagnosis of osteoarthritis, for instance, is such a common one, often being made several times a day, so it is easy to become matter of fact about it; yet for the client that news may actually be quite traumatic and the impact hugely underestimated."

• Asked to rate pain, dog owners perceived the most painful condition to be a broken leg.
• On a 0 to 10 scale, with 10 being most painful, 57% rated pain due to chronic arthritis in old age as 8 or above and 36% rated post-neutering pain as an 8 or above.
• Fewer people rated pain due to arthritis in a young dog as 8 or above (51%). Vetoquinol says this suggests that owners might not be good at identifying pain levels in individual animals.

Where clients get their information from is important:

• 98% said they would use the Internet to get information about their dogs' illnesses and medication, whilst 67% said they would do this every time they had a concern. Vetoquinol notes that this means there is greater scope for misinformation.

The majority of respondents (95%) felt that treatment of osteoarthritis should be started as soon as signs appear and then long term, either consistently or as needed. However, despite recognising the need for treatment, many expressed concerns about side effects when giving their dog long-term medication, with 77% considering it important or very important to choose a medication with a limited range of side effects. 

• 48% of those polled felt that NSAIDs were good treatments with a risk of side effects
• 15% rated them more positively as good, effective treatments
• 2% claimed they would object to or resist their vet's recommendation to treat with NSAIDs.
• Only 1% felt that pain controlling medications would never cause side effects, with most respondents claiming side effects were most likely to be seen sometimes (67%) or often (19%).

Vetoquinol says the reality is that one in a thousand pets given an NSAID is likely to experience side effects, which vets may feel is not something owners should worry about unduly. The reality for pet owners is that they perceive the risk to be much greater and if informed of the actual level of risk may still experience a significant level of fear that their pet, with whom they have a special relationship, could be that one in a thousand.

Mark Leddy says that, based on these results, there is great scope for the veterinary team to discuss the level and type of risk entailed in administering medication: "Such an approach will help pet owners make more informed decisions about treatment, allay their concerns and provide them with the support they need at what is probably a very difficult time for them."

^1. A survey of 1048 dog owners, carried out by petbuzz, on behalf of Vétoquinol, March 2011

Identi has launched a Practice Pet Protection Pack to help vet professionals answer questions about microchipping before cat microchipping becomes compulsory in England from 10th June.

The pack contains species-specific microchipping law guides, a practice registration guide, a cat chipping cheat sheet, flyers about registration and flyers about Identi’s silent microchipping scanner.

The company has also produced three short videos with more information for vet professionals about Identi, what it does, registering microchips and compulsory cat microchipping.

Tammie O’Leary, commercial lead at Identi, said: “From June 10th, it will be compulsory that owned cats in England are microchipped and registered in the same way. 

"With these changes imminent, it is important that staff are up to date with the relevant legislation and the potential consequences of pet keepers not adhering to the law. 

"identi’s new Practice Pet Protection Pack will provide busy vet professionals with comprehensive information answering a wide range of microchipping questions in a quick and simple format.”

For a copy of the Practice Pet Protection Pack, email: contact@identichip.co.uk

The RCVS Charitable Trust is offering up to 10 grants worth around £500 each, to support UK veterinary surgeons looking to pursue themes of clinical or non-clinical research involving short-term visits to veterinary or medical centres, or research institutes, outside the UK.

The Travel Awards are open to registered members of the RCVS, as well as to candidates registered for a PhD at a UK veterinary school. The awards are available for up to 12 months from the award date, and awards cannot be made for projects taking place before 31 October 2011.

The successful candidates will be asked to submit an article to the veterinary press and provide the Trust with a diary record including photographs, and/or short video.

All applications must be received by 5pm on Monday 31 October 2011.

Further information including full application criteria, is available from www.rcvstrust.org.uk/grants/

Alternative, contact grants@rcvstrust.org.uk or call 0207 202 0741.

Kruuse has announced that it is now the exclusive veterinary distributor in the UK, Europe, Australia and New Zealand for Nurtured Pets' Anti-LickStrip pet plaster, a natural hypo-allergenic adhesive plaster that deters licking, biting and chewing.

Anti-LickStrip's plaster is made with active ingredients including cayenne pepper, oregano, lemon powder and peppermint that acts as a deterrent to the animal when sniffed, licked or bitten. The veterinary range of Anti-Lick products will be co-branded under the Kruuse 'Buster' brand as: Buster Anti-LickStrip (sizes: small, medium and large) Buster Anti-LickStrip Pro and Buster Anti-LickStrip Pro C.

Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This agreement further expands Kruuse's small animal product portfolio with its customer in Scandinavia, mainland Europe and the UK; increasing the already extensive range of animal tamper deterrents available to the veterinary practitioner."

Lisa Huntsman, President, Lauren Manufacturing & Nurtured Pets said: "This exciting partnership will further expand our products presence within the veterinary industry expanding our delivery of focused health and wellness products to customers, using Kruuse's strong relationships within veterinary practices."

XLVets, the cooperative of independent practices, has decided to share its resources with independent practices that are not currently members.

XLVets has called on experts in people development, legal, IT and HR, as well as its practice owners, managers and team leaders to develop a package of coronavirus resources. The package includes guidance and best practice, tips offered by XLVets members, expert guidance in the use of technology to support home workers, access to the XLVets Thriving in Practice wellbeing initiative and more. 

To access the resources at www.xlvets.co.uk without charge or obligation, email admin@xlvets.co.uk.

Colm McGinn (pictured right), from XLVets said: "We are very good at working together to develop solutions for problems and supporting each other. This is a national challenge and while our members have faced some difficult decisions, they've been able to share that decision-making process with their peers, calling on them for ideas, guidance and support.

"It's a big ask for just one or two partners to interpret the guidance in a rapidly changing environment and to stay informed about advice from regulatory bodies and associations. We've all benefited from sharing knowledge and it's lifted some of the pressure that comes from taking individual action, while still having freedom to do what's right for your own practice and people. I can't think of a better time for us to share our learning and resources for the greater good."

For more information, visit: https://www.xlvets.co.uk/the-boss. 

A research project funded by equine charity The Horse Trust has found that 40% of horses suffered a traumatic injury within the past year.

Only 13% of injuries occurred during ridden exercise, while 62% occurred while the horse was turned out in the field.

The research, which has been accepted for publication by the Equine Veterinary Journal, was carried out by Rosie Owen, who is currently working as The Horse Trust's Clinical Scholar in Equine Orthopaedics at the University of Liverpool.

Rosie said: "This Horse Trust-funded research shows that horses get injured relatively frequently - much more often than you would expect. Interestingly, most of the injuries happen during turnout, rather than during ridden exercise."

The results were obtained through analysing the responses from 652 randomly selected horse owners from north-west England, Midlands and North Wales, all of whom had a horse aged 15 years or younger. Owners sought veterinary treatment for 47% of the injuries reported, while the remainder were treated by the owner or a friend, or required no treatment.

Rosie identified a number of factors that were associated with an increased risk of injury. For example, horses that had been owned for a shorter period of time were found to be significantly more at risk of injury. She says the increased risk may be due to aggression from other horses when a new horse is introduced to a field, but owners can take various steps to reduce the likelihood of injury: "It's worth trying to avoid regular changes in group composition. A new horse should be introduced to the group gradually, preferably by providing adjacent stabling initially. Protective boots may help as the lower limbs are most at risk of injury. Also, if possible, the other horses in the field should have their shoes taken off during the period of adjustment, so they are less able to injure the new horse."

Rosie also found that horses turned out within larger groups were at an increased risk of injury. This is probably due to there being a larger hierarchy with multiple horses competing for dominance. However, she found that the risk of injury reduced when additional feeding areas were provided in the field: "If you provide hay or haylage to horses in the field, it's worth including an additional feeding area to reduce competition for food."

Other interesting findings included the lower incidence of injury in cob and pony breeds, compared to other breeds. Horses used competitively also had a higher risk of injury, which may be due to the additional athletic demands placed on these horses, or due to the way these horses are managed. Horses trained using Parelli methods were also found to be at an increased risk of injury, but as the numbers in this group were small, more research is needed to confirm this.

Although most of the injuries recorded in the survey occurred during turnout, 11% occurred in the stable, with most of the injuries affecting the head or eye. Rosie says owners can easily reduce the risk of stable injury: "There are various simple steps that owners can take to reduce the risk of injury in the stable. Try to provide hay from the floor, instead of in a hay rack, and make sure there are no protruding nails, hooks or sharp edges in the stable."

Rosie said that it would be useful to conduct further research to understand how injuries occur during turnout: "A lot of injuries are reported during turnout, but we're uncertain about what happened. It would be useful to observe the behaviour of horses in the field to see whether it's competition for food, or another factor, that is responsible for the high rate of injuries among horses."

Jeanette Allen, Chief Executive of The Horse Trust, said: "We are pleased that the research we've funded has provided such useful statistics on the risks of injury for horses. We hope that horse owners will follow some of the tips that Rosie has suggested to reduce the risk of their horse being injured."

Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.

The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.

During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.

Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.

Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.

“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”

For more information, visit www.zoetis.co.uk/apoquel.

The Purina Institute is holding a one-hour webinar about helping clients identify credible sources of information that address their questions and concerns about petfoods on 14^th July at 6pm BST.

Aimed at all members of the veterinary team across Europe, the webinar is moderated by veterinary nutrition expert Dottie Laflamme. 

The webinar, which will also be available on demand after the event, follows others in the series that allow conversations about nutrition to be integrated into everyday consultations.

Speakers Shoshanah Verton Shaw, RVT, VTS (nutrition), and Marge Chandler  (a diplomate of the American College of Veterinary Internal Medicine, the European College of Veterinary Internal Medicine and the American College of Veterinary Nutrition) will be sharing their tips for handling nutrition discussions in a non-confrontational way that preserves the client bond with the vet and the practice. 

Registration for this and another three free webinars is available at https://bit.ly/purinawebinars2022.

Hot on the heels of Vets Now and the BVA, Linnaeus has launched new resources to support the 5000-odd members of its workforce that will going through the menopause.

The resources comprise guidance materials, a health and wellbeing assessment, associate case studies, links to external support and information posters.

The company is also piloting a mindfulness app called Headspace, which is now freely available to everyone at Linnaeus, whether they are experiencing the menopause or have other needs.

Saskia Connell, People and Organisation Director at Linnaeus, said: “Menopause is a stage of life that is unique for everyone who experiences it – and can also affect the people around them.

"For those experiencing the menopause, sadly 45% say they feel their symptoms have had a negative impact on their work, according to the British Menopause Society.

"As an employer, we need to make sure they have our full support and a flourishing career.

One of Linnaeus' practices, Park Vet Group, has taken things a step further and introduced other wellbeing initiatives to support its associates with the menopause.

The practice offers confidential support to all associates who want to talk about any health concerns, plus open sessions to establish conversations about menopause.

Its team, led by Practice Manager Harriet Tims (pictured right), also introduced yellow 'Just to Make you Smile' toiletry bags containing sanitary products, tissues, hygiene wipes, deodorant spray and face wipes.

Anyone at Park can help themselves to the bags, or add products should they wish.